Risky Drinkers and the Web: a RCT Study in Region Friuli-Venezia Giulia.

NCT01638338 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 674

Last updated 2017-07-06

No results posted yet for this study

Summary

The project aims to develop a new approach to risky drinkers by providing a facilitated website access and creating a local integrated support network.

In order to do so:

1\) A non inferiority-randomised controlled study will be performed to test the hypothesis that: Brief intervention for risky drinkers delivered in primary care through facilitated access to an alcohol reduction website has non inferior outcomes to face to face brief intervention.

Conditions

  • Excessive Drinking

Interventions

BEHAVIORAL

Web assisted brief motivational interview on risky drinking

People allocated to this arm will be given a password to enter and follow a pre-decided set of questions and hints to reduce their drinking

BEHAVIORAL

Face to Face

The counseling provided by the GPs will be done at month 0, 6, 12

Sponsors & Collaborators

  • Ministry of Health, Italy

    collaborator OTHER_GOV
  • Istituto Superiore di Sanità

    collaborator OTHER
  • University of Leeds

    collaborator OTHER
  • Federsanità, ANCI

    collaborator UNKNOWN
  • Codeface Ltd.

    collaborator UNKNOWN
  • Azienda Per I Servizi Sanitari N. 2 Isontina

    lead OTHER

Principal Investigators

  • Paul Wallace, prof · Leeds University

  • Emanuele Scafato, prof · Istituto Superiore di Sanità

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-01
Primary Completion
2015-12-30
Completion
2015-12-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01638338 on ClinicalTrials.gov